Stocktoria

MARIMED INC. MRMD

OTC · stock · Medicinal Chemicals & Botanical Products · website · IPO 2012-05-04

MARIMED INC. (MRMD) earns a Piotroski F-score of 4/9 (mixed financial health), with an Altman Z″ in the distress zone. It does not currently pay a dividend. FY2025 revenue was $159.8M at a -9.1% net margin.

$0.15 high · $0.06 low · daily closes (~2y) · hover for date & price
27/100
Stocktoria Quality Score · grade D
4/9
Piotroski F — financial health
-1.76
Altman Z″ — distress risk · distress
Dividend yield · no dividend
-2.97
Beneish M-score — earnings quality · low

Quality score trend · recomputed for each fiscal year

Piotroski F /9
5 3 3 2 7 6 4 3 4 4 2016201720182019202020212022202320242025
Altman Z″
-6.38 -2.77 2.08 -13.19 -3.21 0.59 0.92 0.19 -1.12 -1.76 2016201720182019202020212022202320242025

Each year's score is computed from that year's filing — a rising Piotroski F or Altman Z″ means improving financial health, a fall is worth a look.

$0.09 as of 2026-08-01 · -42.2% 1y
$0.06$0.1552-wk

Beneish M-score: -2.97 — low (below −2.22 — no manipulation red flag) . A statistical screen for earnings manipulation, not proof — and it doesn't apply to most banks/insurers.

Market cap USD$28M
Net margin 5y avg-2.4%
Beta1.32
Employees808

Analyst price target

$0.25 +180.9% vs last
· 1 analysts
target range $0.25 – $0.25

Wall Street analyst consensus — a sentiment gauge, not our scoring.

Revenue trend · last 10y · up

How it ranks in Manufacturing · percentile among 1995 companies

Piotroski Fstronger than 45%
Net marginstronger than 41%
Return on equitystronger than 37%
Revenue growthstronger than 38%

Percentile vs other Manufacturing companies we cover — e.g. “stronger than 90%” means only 10% score higher on that measure.

Piotroski F breakdown · 4/9 tests passed

Altman Z″ components · distress zone

ComponentValue
Working capital / assets0.001
Retained earnings / assets-0.632
EBIT / assets-0.014
Equity / liabilities0.363

Sector peers · similar-size Manufacturing companies compare side by side →

TickerCompanyPiotroski FAltman Z″P / ERevenue growth
MRMDMARIMED INC.4/9-1.76+1.3%
GLASGlass House Brands Inc.3/9-1.45-9.4%
NAIINATURAL ALTERNATIVES INTERNATIONAL INC5/93.07+14.1%
NAGENiagen Bioscience, Inc.5/93.4215.7+29.9%
BTMDbiote Corp.5/90.922.5-2.5%
CRONCronos Group Inc.6/9+19.5%
MTEXMANNATECH INC2/9-1.37-8.3%

All Manufacturing companies →

About MARIMED INC.

MariMed Inc. engages in cultivation, production, and selling of branded cannabis products in the United States. The company sells cannabis flower, vapes, and concentrates under the Nature's Heritage brand; and cannabis fruit chews that delivers better sleep, pain relief, stress relief, and others under Betty's Eddies brand. It offers soft and chewy baked goods and a hot chocolate mix under Bubby's Baked brand; cannabis-infused hydrating drink mix for discrete and on-the-go consumption under Vibations brand; and flower, vapes, and edibles under InHouse brand. The company licenses its brands. MariMed Inc. was incorporated in 2011 and is headquartered in Norwood, Massachusetts.

FAQ

Is MRMD financially healthy?

MARIMED INC.'s Piotroski F-score is 4/9 (8–9 is excellent, 0–3 weak), and its Altman Z″ distress score is in the distress zone.

Does MRMD pay a dividend?

No, MARIMED INC. does not currently pay a dividend.

How profitable is MRMD?

In FY2025, MARIMED INC. had a net margin of -9.1% and a return on equity of -29.0%.

What is the analyst price target for MRMD?

The average Wall-Street price target for MARIMED INC. is $0.25, about 180.9% above the recent price, from 1 analysts.

Is MRMD a good stock to buy?

Stocktoria doesn't give buy or sell advice, but here is the data on MARIMED INC.: a Piotroski F-score of 4/9, an Altman Z″ in the distress zone. Weigh these quality and valuation signals against your own goals.

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.